Aspen business in licensing deal with GSK
JSE listed Aspen Pharmacare Holdings Limited (Apn) has announced that it has entered into licensing and supply agreements with leading multinational pharmaceutical corporation, GlaxoSmithKline (“GSK”). 24 Jul 2008 09:00
Recruit patients quick with a click
The clinical drug trials required to ensure the next Avastin, Viagra or Lipitor actually make it to market are often lasting longer than expected. In fact, 90% of trials are delayed, and the majority of these delays are attributed to patient recruitment problems, perhaps as patient recruitment takes longer than any other step of the trial and the public perception of the clinical trial process and pharmaceutical industry on the whole is largely very negative. 22 Jul 2008 07:19
DNA labelling for drug security?
German logistics firm Movianto GmbH has developed what it considers to be the most effective protection against the infiltration of counterfeit drugs into the supply chain: DNA labelling. In a statement, the firm noted that the proportion of counterfeit products has recently been reported by the European Commission to be rapidly increasing. 14 Jul 2008 07:43
Aspen win tender for antiretrovirals for Department of Health
Antiretroviral tender results 27 Jun 2008 08:44
Pfizer completes acquisition of Encysive Pharmaceuticals Inc
Pfizer Inc (NYSE:PFE) recently announced that it has completed the acquisition of all remaining outstanding shares of common stock of Encysive Pharmaceuticals Inc. (NASDAQ:ENCY) through a merger of Pfizer's wholly-owned subsidiary, Explorer Acquisition Corp., with and into Encysive. Encysive is now a wholly-owned subsidiary of Pfizer. 24 Jun 2008 12:40
Cipla secures alliance with X/Procure®
Cipla Medpro believes that all South Africans should have access to world class, but affordable medicines, lessening the burden of high drug costs and bettering the health and lives of all South Africans. 16 Jun 2008 11:20
Pharmacovigilance in the spotlight
[Ruchi Mallya] Predictive and proactive pharmacovigilance paves the road for drug safety solutions. 5 Jun 2008 06:27
Pharma moving to more restricted drug distribution, in attempt to guard drug supply chain
Ideally, drug supply should be a simple and transparent chain that connects the manufacturer and patient in as few steps as possible. However, in practice it can be a highly circuitous one that includes several intermediaries before reaching a pharmacy. Notwithstanding the possibility that drug integrity can be compromised in transit, complex supply chains risk counterfeit drug entry. 15 May 2008 06:10
Leading ED treatment celebrates five years in South Africa
Lilly's treatment for erectile dysfunction still market leader 24 Apr 2008 08:42
‘Conservative' pharma slow to take advantage of online marketing opportunities
[Dr Sandra Reynolds] While the internet has altered the landscape in the retail sector and revolutionised the airline industry, pharmaceutical companies have been slow to take advantage of the marketing opportunities offered by the internet. However, the same cannot be said of customers, who are increasingly using the web to source information. 23 Apr 2008 08:35
Cash-strapped governments, patent expiries, fuel generics growth
[Pam Narang] Driven by the increasing use of cost-containment measures imposed by cash-strapped governments and fed by a constant stream of patent expiries going forward, the global generics market continues to grow. 17 Apr 2008 06:00
Pharma must adapt to changing market dynamics in 2008
Headaches abound for pharma companies in today's market. Pharma faces growing competition from generics and ‘me-too' drugs, increasingly tough pricing and reimbursement (P&R), a clamp down on healthcare spending, and the need to treat patients for longer due to the aging population. Combined, these factors threaten both current and future revenues, prompting Pharma to adopt a range of corporate strategies to respond to the changing market dynamics, according to a new report by independent market analyst Datamonitor. 11 Apr 2008 06:00
Pfizer Oncology draws top advocates for R&D summit
Leaders of premier advocacy organizations from around the world will meet with Pfizer Oncology to discuss the latest advances in cancer research and identify opportunities to work together. 3 Apr 2008 17:29
Next page>>News for medical professionals
Nothing depressing about launch of Cipla's Lexamil 8 May 2008 09:26
Avastin now used for the treatment of patients with metastatic colon cancer in Europe 29 Jan 2008 10:14
Next page>>
Connected by: Uninet
